CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements

Warfarin continues to be the mainstay therapy for preventing thrombus formation. Although pharmacogenetic algorithms have shown higher predictability of the optimal warfarin dose and lower occurrence of bleeding episodes, they often do not include ethno-specific genetic variants relevant to non-Euro...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pharmacogenomics
Main Authors: Claudio-Campos, Karla I, González-Santiago, Pablo, Renta, Jessica Y, Rodríguez, Jovaniel, Carrasquillo, Kelvin, Gaedigk, Andrea, Roche, Abiel, Ducongé, Jorge
格式: Artigo
語言:Inglês
出版: Future Medicine Ltd 2019
主題:
Case Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6479273/
https://ncbi.nlm.nih.gov/pubmed/30518301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2018-0143
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍